SEOUL (Xinhua) – South Korea’s drug safety agency said on Friday it conditionally approved the country’s first homegrown COVID-19 treatment candidate, developed by local pharmaceutical giant Celltrion. More details in Saturday’s Borneo Bulletin.
SEOUL (Xinhua) – South Korea’s drug safety agency said on Friday it conditionally approved the country’s first homegrown COVID-19 treatment candidate, developed by local pharmaceutical giant Celltrion. More details in Saturday’s Borneo Bulletin.
